Kymera IPO Presentation Deck

~$400M Raised Capital raised since inception, equally split between equity sales and partnership upfronts ~$300M+ On Hand Current cash and cash equivalents (includes upfront from Sanofi collaboration) Cash runway beyond early 2025 Current expected cash runway based on operational plans, IPO and concurrent private placements, excludes any milestones from collaborations KYMERA Financial Highlights ATLASVENTURE Series A/B (~$96M Raised) AMGEN' Ventures Pfizer Ventures 和天 Academic Collaborators LILLYVENTURES HATTERAS SANOFI VENTURES BESSEMER UCSF MERCK VERTEX Yale MAYO CLINIC Series C: March 2020 (~89M Raised) BVF WELLINGTON MANAGEMENT" BlackRock Janus Henderson -INVESTORS COLUMBIA UNIVERSITY Redmile Group UNIVERSITY OF CAMBRIDGE BainCapital LIFE SCIENCES ROCK SPRINGS CAPITAL LOGOS CAPITAL Radboud University

View entire presentation